Mimedx (MDXG) Change in Accured Expenses (2011 - 2026)

Mimedx has disclosed Change in Accured Expenses across 16 years of filings, most recently posting -$1.3 million for Q2 2026.

• In Q2 2026, Change in Accured Expenses fell 117.75% year-over-year to -$1.3 million; the TTM figure through Jun 2026 stood at -$11.6 million (down 204.17% YoY), while the FY2025 annual figure was $9.0 million, up 210.29% from the prior year.
• Change in Accured Expenses came in at -$1.3 million for Q2 2026 at Mimedx, up from -$15.7 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $8.0 million in Q3 2022 to a low of -$15.7 million in Q1 2026.
• Average Change in Accured Expenses over 5 years is -$54333.3, with a median of $416500.0 recorded in 2022.
• Year-over-year, Change in Accured Expenses jumped 2925.65% in 2025 and plunged 285.61% in 2026.
• Over 5 years, Change in Accured Expenses stood at $655000.0 in 2022, then surged by 525.5% to $4.1 million in 2023, then gained by 2.59% to $4.2 million in 2024, then slipped by 18.75% to $3.4 million in 2025, then sank by 139.5% to -$1.3 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$1.3 million in Q2 2026, -$15.7 million in Q1 2026, and $3.4 million in Q4 2025.